Skip to main content

Find Clinical Trials

Home
Conditions
Hepadnaviridae Infections

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,160 public trials 112 recruiting studies

Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV

NCT00645294

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Cliniques Universitaries Brussels, Belgium

J.W. Goethe-Universitat Frankfurt, Germany

Mid. Hochschule Hannover Kinderklinik Hanover, Germany

Kinderklinik der Gutenberg Universitat Mainz, Germany

View Trial Details

Completed

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

NCT00023153

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +25 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Lamivudine for Chronic Hepatitis B

NCT00001457

Conditions: Arteritis, Blood-Borne Infections, Cardiovascular Diseases, +37 more
Locations: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States

View Trial Details

Completed

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

NCT00013702

Conditions: Ascites, Blood-Borne Infections, Bronchial Diseases, +33 more
Locations: National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States

View Trial Details

Completed

Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan

NCT00001712

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +23 more
Locations: National Institutes of Health Clinical Center (CC) Bethesda, Maryland, United States

View Trial Details

Completed

Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT

NCT00230477

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Harborview Medical Center Seattle, Washington, United States

View Trial Details

Completed

VaxTeen Hepatitis B Vaccine Booster Study

NCT00144313

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: CDC Arctic Investigations Program Anchorage, Alaska, United States

View Trial Details

Completed

Long Term Follow-up of Pegylated-Interferon Alpha-2b

NCT00146705

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: University Medical Center Rotterdam Rotterdam, Dr Molewaterplein 40, Netherlands

View Trial Details

Completed

ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency

NCT00493506

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +23 more
Locations: Laboratory of Nutrition and Nutritional Biochemistry (LNNB), Department of Biochemistry, University of Yaounde I Yaoundé, Cameroon

View Trial Details

Completed

Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection

NCT00127959

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +18 more
Locations: Academic Medical Center Amsterdam, North Holland, Netherlands

View Trial Details